Cencora, Inc. (COR) Market Cap & Valuation Ratios
Cencora, Inc. (COR) has a market cap of $63.2B, a trailing P/E of 24.6 and a price-to-sales ratio of 0.2, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CORCencora, Inc.Follow COR — free
—
Price chart with a free account
- Market cap
- 63.2B
- P/E TTM
- 24.6
- Dividend yield
- 0.7%
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Peers
medical distribution · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| COR | 63 | 24.6 | 0.2 | 17.7 | 6.4% | +5% | 0.9% | 22% |
| MCK | 117 | 26.8 | 0.3 | 16.7 | 5.3% | +9% | 2% | 287% |
| CAH | 58 | 34.5 | 0.2 | 17.4 | 7.8% | +14% | 1% | 136% |
| HSIC | 9.5 | 24.8 | 0.9 | 12.7 | 5.4% | +6% | 5% | 8% |
| ACH | 0.0 | — | 0.7 | 6.1 | — | -3% | 1% | 2% |
| MEDS | 0.0 | — | 4.5 | — | — | -78% | — | -418% |
| Median of these 5 | 26.8 | 0.7 | 14.7 | 5.4% | +6% | 1% | 8% |
P/E 24.6 vs. a peer median of 26.8; EV/Sales 0.2 vs. 0.7. COR's own P/E sits at the 57th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesACH and MEDS have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Cencora, Inc. — questions
- What is Cencora, Inc.'s market cap?
- $63.2B.
- What is Cencora, Inc.'s P/E ratio?
- 24.6 on trailing twelve-month earnings to 2026-06-30.
- What is Cencora, Inc.'s price-to-sales ratio?
- 0.2.
Every figure on this page comes from Cencora, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.